Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: A case study from urban southeast Nigeria
- PMID: 36417829
- DOI: 10.1016/j.dsx.2022.102665
Comparison of diagnostic criteria and prevalence of metabolic syndrome using WHO, NCEP-ATP III, IDF and harmonized criteria: A case study from urban southeast Nigeria
Abstract
Background and aims: Metabolic syndrome (MetS) is a worldwide public health problem, affecting not just developed countries but also developing countries and impacts all age groups. Different criteria are available for its assessment. The present study aims at comparing the prevalence of MetS using four criteria.
Methods: A total of 4202 (male: 2772 and female: 1430) with mean age 41.23 ± 9.58 years participated in the study. For all definitions, presence of 3 abnormalities out of 5 qualify an individual for MetS. Various statistical analyses including unpaired student's t-test, chi-square crosstabs (or Fisher's exact test where appropriate), analysis of variance, logistic regression, receiver operating characteristic (ROC) curve and Cohen's Kappa were performed.
Results: The prevalence of MetS were 17.1%, 21.8%, 11.4% and 23.6% for National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III (NCEP-ATP III), International Diabetes Federation (IDF), World Health Organization (WHO) and the Harmonized definitions respectively. Further, the order of significance of screening components for MetS is elevated blood pressure (BP) > impaired fasting glucose > abdominal adiposity. Whereas, the order of significant performance of the four screening tools are Harmonized > IDF > NCEP-ATP III > WHO.
Conclusion: The prevalence of MetS among young adults in southeast Nigeria was moderately high. The Harmonized definition was the best screening tool for MetS. High BP was the most sensitive and specific screening tool for detecting risk of MetS.
Keywords: Metabolic syndrome; Prevalence; Raised blood pressure; Southeast Nigeria.
Copyright © 2022 Research Trust of DiabetesIndia (DiabetesIndia) and National Diabetes Obesity and Cholesterol Foundation (N-DOC). Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria.J Diabetes Metab Disord. 2014 Nov 23;13(1):104. doi: 10.1186/s40200-014-0104-3. eCollection 2014. J Diabetes Metab Disord. 2014. PMID: 25469328 Free PMC article.
-
Prevalence of metabolic syndrome in Gwalior region of Central India: A comparative study using NCEP ATP III, IDF and Harmonized criteria.Diabetes Metab Syndr. 2019 Jan-Feb;13(1):816-821. doi: 10.1016/j.dsx.2018.12.003. Epub 2018 Dec 8. Diabetes Metab Syndr. 2019. PMID: 30641814
-
Evolution of Metabolic Syndrome in Newly Diagnosed Type 2 Diabetes Mellitus Asian-Indian Patients Over the Last 15 Years using Adult Treatment Panel III of the National Cholesterol Education Program, World Health Organization, and International Diabetes Federation Criterion.J Assoc Physicians India. 2024 Jun;72(6):39-43. doi: 10.59556/japi.72.0563. J Assoc Physicians India. 2024. PMID: 38881133
-
Prognostic interactions between cardiovascular risk factors.Dan Med J. 2014 Jul;61(7):B4892. Dan Med J. 2014. PMID: 25123126 Review.
-
Prevalence of Metabolic Syndrome in Mexico: A Systematic Review and Meta-Analysis.Metab Syndr Relat Disord. 2018 Oct;16(8):395-405. doi: 10.1089/met.2017.0157. Epub 2018 Jul 31. Metab Syndr Relat Disord. 2018. PMID: 30063173
Cited by
-
Prevalence and correlates of metabolic syndrome among adults in freetown, Sierra Leone: A comparative analysis of NCEP ATP III, IDF and harmonized ATP III criteria.Int J Cardiol Cardiovasc Risk Prev. 2024 Jan 14;20:200236. doi: 10.1016/j.ijcrp.2024.200236. eCollection 2024 Mar. Int J Cardiol Cardiovasc Risk Prev. 2024. PMID: 38299125 Free PMC article.
-
The effect of a new developed synbiotic yogurt consumption on metabolic syndrome components in adults with metabolic syndrome: a randomized controlled clinical trial.Nutr Diabetes. 2024 Dec 18;14(1):97. doi: 10.1038/s41387-024-00354-7. Nutr Diabetes. 2024. PMID: 39695092 Free PMC article. Clinical Trial.
-
Combined effects of sodium alginate supplementation with HIIT and MICT on CCK and PYY levels in men with metabolic syndrome.J Diabetes Metab Disord. 2025 Jun 16;24(2):150. doi: 10.1007/s40200-025-01664-y. eCollection 2025 Dec. J Diabetes Metab Disord. 2025. PMID: 40534635
-
Relationship between bullous pemphigoid and metabolic syndrome and its relevant traits: a bidirectional two-sample Mendelian randomization study.Arch Dermatol Res. 2025 Jan 6;317(1):180. doi: 10.1007/s00403-024-03704-8. Arch Dermatol Res. 2025. PMID: 39760936
-
Prevalence of Metabolic Syndrome in Vitiligo Patients and Its Relation to Vitiligo Severity - A Cross-Sectional Study.Indian Dermatol Online J. 2024 Oct 28;15(6):1056. doi: 10.4103/idoj.idoj_710_24. eCollection 2024 Nov-Dec. Indian Dermatol Online J. 2024. PMID: 39640440 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical